XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

180 hedge funds and large institutions have $2.1B invested in Xenon Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 50 reducing their positions, and 14 closing their positions.

Holders
180
Holders Change
+6
Holders Change %
+3.45%
% of All Funds
2.87%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.14%
New
22
Increased
71
Reduced
50
Closed
14
Calls
$10.9M
Puts
$19.2M
Net Calls
-$8.29M
Net Calls Change
-$10.4M

Top Buyers

1
Pictet Asset Management
1
Pictet Asset Management
Switzerland
$66.2M
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$37M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$38.5M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$59M
5
PBA
5
Paradigm Biocapital Advisors
New York
$51M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$145M
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$39.3M
3
RG
3
Redmile Group
California
$14.3M
4
PA
4
Perceptive Advisors
New York
$21.1M
5
Holocene Advisors
5
Holocene Advisors
New York
$6.1M
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$167M 4,900,000 – –
DCM
2
Driehaus Capital Management
Illinois
$154M 4,513,005 -247,848 -5%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$145M 4,252,866 -935,841 -18%
PCH
4
Polar Capital Holdings
United Kingdom
$103M 3,003,747 -18,324 -0.6%
Capital International Investors
5
Capital International Investors
California
$83.6M 2,446,820 +124,829 +5%
Capital World Investors
6
Capital World Investors
California
$77.7M 2,274,974 – –
Marshall Wace
7
Marshall Wace
United Kingdom
$73.6M 2,154,394 -166,025 -7%
B
8
Braidwell
Connecticut
$71.9M 2,103,396 +275,043 +15%
Pictet Asset Management
9
Pictet Asset Management
Switzerland
$66.2M 1,938,779 +1,938,779 New
CC
10
Commodore Capital
New York
$63M 1,845,000 – –
BI
11
BVF Inc
California
$62.4M 1,827,958 – –
Wellington Management Group
12
Wellington Management Group
Massachusetts
$59M 1,728,108 +677,057 +64%
PBA
13
Paradigm Biocapital Advisors
New York
$51M 1,491,835 +502,508 +51%
RSCM
14
Rock Springs Capital Management
Maryland
$40.2M 1,178,002 – –
Lord, Abbett & Co
15
Lord, Abbett & Co
New Jersey
$39.3M 1,149,168 -809,372 -41%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$38.5M 1,125,708 +977,500 +660%
AllianceBernstein
17
AllianceBernstein
Tennessee
$37M 1,084,337 +1,018,321 +1,543%
BlackRock
18
BlackRock
New York
$33.9M 991,457 -2,583 -0.3%
O
19
OrbiMed
New York
$32.8M 958,793 -137,207 -13%
SC
20
Samlyn Capital
New York
$32.5M 951,755 +11,846 +1%
NIP
21
Nicholas Investment Partners
California
$29.2M 854,447 +63,329 +8%
BBA
22
Baker Bros. Advisors
New York
$25.7M 751,639 – –
Loomis, Sayles & Company
23
Loomis, Sayles & Company
Massachusetts
$25M 730,716 -22,810 -3%
Citadel Advisors
24
Citadel Advisors
Florida
$24.7M 723,524 +222,512 +44%
Invesco
25
Invesco
Georgia
$24.5M 716,303 +16,318 +2%
1
2 3 4 5